Use of frequency distribution curves, scattergrams and regression analyses to compare in vitro activities and describe cross-susceptibility and cross-resistance among four quinolonesFASS, R. J.Journal of chemotherapy. 1994, Vol 6, Num 6, pp 368-376, issn 1120-009XArticle

Erythromycin, clarithromycin, and azithromycin : use of frequency distribution curves, scattegrams, and regression analyses to compare in vitro activities and describe cross-resistanceFASS, R. J.Antimicrobial agents and chemotherapy. 1993, Vol 37, Num 10, pp 2080-2086, issn 0066-4804Article

In vitro activity of Bay y 3118, a new quinoloneFASS, R. J.Antimicrobial agents and chemotherapy. 1993, Vol 37, Num 11, pp 2348-2357, issn 0066-4804Article

Eficácia e segurança da ciprofloxacina oral no tratamento de infecções respiratórias graves = Efficacy and safety of oral ciprofloxacin in the treatment of serious respiratory infectionsFASS, R. J.Arquivos brasileiros de medicina. 1990, Vol 64, Num 2, pp 114-118, issn 0365-0723, 5 p.Article

In vitro activity of ciprofloxacin (Bay o 9867)FASS, R. J.Antimicrobial agents and chemotherapy. 1983, Vol 24, Num 4, pp 568-574, issn 0066-4804Article

Statistical comparison of the antibacterial activities of broad-spectrum penicillins against gram-negative bacilliFASS, R. J.Antimicrobial agents and chemotherapy. 1983, Vol 24, Num 2, pp 156-162, issn 0066-4804Article

The quinolonesFASS, R. J.Annals of internal medicine. 1985, Vol 102, Num 3, pp 400-402, issn 0003-4819Article

In vitro activity of Bay 12-8039, a new 8-methoxyquinoloneFASS, R. J.Antimicrobial agents and chemotherapy. 1997, Vol 41, Num 8, pp 1818-1824, issn 0066-4804Article

In vitro activity of BAY v 3522, a new oral cephalosporinFASS, R. J.Antimicrobial agents and chemotherapy. 1990, Vol 34, Num 9, pp 1855-1857, issn 0066-4804, 3 p.Article

Comparative in vitro activities of third-generation cephalosporinsFASS, R. J.Archives of internal medicine (1960). 1983, Vol 143, Num 9, pp 1743-1745, issn 0003-9926Article

Aetiology and treatment of community-acquired pneumonia in adults : an historical perspectiveFASS, R. J.Journal of antimicrobial chemotherapy (Print). 1993, Vol 32, pp 17-27, issn 0305-7453, SUPAArticle

Efficacy and safety of oral ciprofloxacin for treatment of serious urinary tract infectionsFASS, R. J.Antimicrobial agents and chemotherapy. 1987, Vol 31, Num 2, pp 148-150, issn 0066-4804Article

The utility of non-β-lactam antimicrobial MICs as markers to distinguish oxacillin-resistant from oxacillin- susceptible strains of Staphylococcus epidermidisFASS, R. J; BARNISHAN, J; AYERS, L. W et al.Diagnostic microbiology and infectious disease. 1996, Vol 26, Num 1, pp 43-45, issn 0732-8893Article

In vitro antistaphylococcal activity of pefloxacin alone and in combination with other antistaphylococcal drugsFASS, R. J; HELSEL, V. L.Antimicrobial agents and chemotherapy. 1987, Vol 31, Num 10, pp 1457-1460, issn 0066-4804Article

In vitro activities of Ro 19-5247 and Ro 15-8074, new oral cephalosporinsFASS, R. J; HELSEL, V. L.Antimicrobial agents and chemotherapy. 1986, Vol 30, Num 3, pp 429-434, issn 0066-4804Article

Emergence of bacterial resistance to imipenem and ciprofloxacin in a university hospitalFASS, R. J; BARNISHAN, J; AYERS, L. W et al.Journal of antimicrobial chemotherapy (Print). 1995, Vol 36, Num 2, pp 343-353, issn 0305-7453Article

Restriction endonuclease analysis of clinical Pseudomonas aeruginosa strains : useful epidemiologic data from a simple and rapid methodMAHER, W. E; KOBE, M; FASS, R. J et al.Journal of clinical microbiology (Print). 1993, Vol 31, Num 6, pp 1426-1429, issn 0095-1137Article

In vitro activity of LY146032 against staphylococci, streptococci, and enterococciFASS, R. J; HELSEL, V. L.Antimicrobial agents and chemotherapy. 1986, Vol 30, Num 5, pp 781-784, issn 0066-4804Article

Comparative in vitro activities of piperacillin-tazobactam and ticarcillin-clavulanateFASS, R. J; PRIOR, R. B.Antimicrobial agents and chemotherapy. 1989, Vol 33, Num 8, pp 1268-1274, issn 0066-4804Article

In vitro activity of U-76,252 (CS-807), a new oral cephalosporinFASS, R. J; HELSEL, V. L.Antimicrobial agents and chemotherapy. 1988, Vol 32, Num 7, pp 1082-1085, issn 0066-4804Article

In vitro activity of RO 23-6240 (AM-833): a new fluoroquinoloneFASS, R. J; HELSEL, V. L.Diagnostic microbiology and infectious disease. 1987, Vol 6, Num 4, pp 293-299, issn 0732-8893Article

In vitro activity of cefpiramide (SM-1652) against gram-negative bacilliFASS, R. J; HELSEL, V. L.Diagnostic microbiology and infectious disease. 1986, Vol 4, Num 1, pp 77-81, issn 0732-8893Article

In vitro activity of carumonamFASS, R. J; HELSEL, V. L.Antimicrobial agents and chemotherapy. 1985, Vol 28, Num 6, pp 834-836, issn 0066-4804Article

Antibiotic-impregnated cement and beads for orthopedic infectionsWININGER, D. A; FASS, R. J.Antimicrobial agents and chemotherapy. 1996, Vol 40, Num 12, pp 2675-2679, issn 0066-4804Article

In vitro activity of DNA gyrase inhibitors, singly and in combination, against Mycobacterium arium complexBABINCHAK, T. J; FASS, R. J.Diagnostic microbiology and infectious disease. 1992, Vol 15, Num 4, pp 367-370, issn 0732-8893Article